EssilorLuxottica strengthens its med-tech strategy with the acquisition of Optegra

EssilorLuxottica has entered into an agreement to acquire Optegra, a rapidly expanding ophthalmology platform operating in several European countries, including the United Kingdom, the Czech Republic, Poland, Slovakia, and the Netherlands. This acquisition is part of EssilorLuxottica's medtech strategy, which aims to offer a comprehensive, digital patient journey integrating AI and advanced technologies.

Optegra comprises a network of more than 70 specialist eye care clinics, offering innovative treatments and surgeries such as cataract surgery and laser eye correction. The transaction is expected to close by the end of 2025, subject to regulatory approvals.